There is an agreement with general practitioners, there are new spaces for vaccinations. The car is in order, but there is not enough petrol. Doses of vaccine are missing. For now the supply is all from abroad and not in the agreed doses. The government is studying a way out and among the hypotheses is that of producing vaccines also in Italy. However, times and methods are to be clarified. The Minister for Economic Development Giancarlo Giorgetti will meet Massimo Scaccabarozzi, president of Farmindustria, an association of companies in the sector.
One of the hypotheses is that the factories where the flu is taken are converted to the production of the Covid vaccine. Another solution proposes it moving part of the vaccine production process to Italy creating a European collaboration that divided production into different countries.
Two hypotheses that clash with the times of reality. The president of Farmindustria explained that in a month the production of the flu shot and if you don’t, there won’t be this drug next year. There are memberships for the production division, but the project needs to be deepened.
Scaccabarozzi explained the difficulties: «A vaccine is a live product, not a synthetic one, it must be treated in a particular way. Must have one bioreazione inside a machine called a bioreactor. In short, it’s not like you press a button and the vial comes out. 4-6 months pass from when a production is started ».
The fundamental question is the bioreactors, these are used for the first part of production and in Italy there are no companies with those necessary for Covid if not Reithera, but for limited numbers and which will be used for the vaccine it is developing. To create useful factories it would take time, at least two years, and even just to transfer this technology from abroad would take 7 months or more. There are instead companies for filling, but the adaptation times would still be there. For now, a company is filling vaccines for AstraZeneca and would also be in the process of making an agreement with Pfizer and Johnson & Johnson.
Given that vaccines will also be needed in the future, this is still a way to go. The European Union itself is asking for it and that is why the minister Giorgetti is doing research to create the vaccines already authorized in Italy: Pfizer, Moderna and AstraZeneca. It would be Europe to deal with the management of patents. Any doses produced in Italy would not remain here: according to the European agreements they should be distributed to everyone and Italy would go to 13.6% of the total.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
